Tag Archives: Heart damage

If the Buffalo Bills want to know if any of their players are vaccine injured, it’s easy to do so, by Steve Kirsch

Posted on January 7, 2023 | 1 comment

It’s fairly straightforward to determine if someone has sustained some sort of heart injury. From Steve Kirsch at stevekirsch.substack.com:

There is a company, HeartCare Corp, that makes a machine that looks like an EKG, but can detect a wide variety of heart damage, including myocarditis. They can assess their team in a day.

Just like Dorothy in the Wizard of Oz could always return to Kansas at any time, the same is true of the Buffalo Bills… if they want to assess whether their players have a heart injury or not, all they have to do is give Heart Care Corp. a call and arrange for a visit to their team.

The HeartCare screening is safe, non-invasive, and takes around 15 minutes.

Then they would know for sure if the COVID vaccine has injured their players. This will save lives.

Sound good?

Does the technology work?

Yes.

They’ve screened vaccinated patients and the rates of clinical and subclinical myocarditis observed is so high you’d never believe I was telling the truth (hint: it’s well over 5% in the general public).

Continue reading→

1 Comment

Posted in Medicine, Science

Tagged ,

New study shows that pretty much everyone is getting heart damage from the COVID vaccines, by Steve Kirsch

Posted on October 22, 2022 | Leave a comment

A chemical marker for heart damage—troponin—shows elevated levels for just about anyone who has received the Covid vaccines. From Steve Kirsch at stevekirsch.substack.com:

They just aren’t letting you know that. In Canada, the medical community is very smart about this: they don’t let doctors measure troponin levels before you are vaccinated so nobody is the wiser.

Executive summary

A new study shows that nearly everyone getting the mRNA COVID vaccines are experiencing some amount of heart damage.

Introduction

A new study out of Switzerland shows that vaccinated people have uniformly higher troponin levels than their unvaccinated peers.

In the graph shown at 6:21, we see that the 777 people who got the booster in this study have uniformly higher troponin levels than their matched unvaccinated peers. That is not supposed to happen. If the vaccines are safe, the troponin levels should be nearly identical between vaccinated and unvaccinated groups.

Here are Professor Prasad’s exact words:

It’s not just the tip of the distribution that has elevated high sensitivity troponin, it’s that the entire distribution is right shifted. Everybody’s having a little bit of elevation in high sensitivity troponin. That’s what this graph would have you infer.

You get a troponin elevation when there is damage to your heart:

Troponin is a type of protein found in the muscles of your heart. Troponin isn’t normally found in the blood. When heart muscles become damaged, troponin is sent into the bloodstream. As heart damage increases, greater amounts of troponin are released in the blood

What the study shows is that nearly everyone is getting a little heart damage when they get the COVID vaccine, some get a lot more damage than others.

Even more important is that it’s not just a little. They are measuring on day 3 and 4 and the slope was going down (See 5:47). So it was presumably much higher before day 3. In other words, the actual damage is likely greater than the curves would indicate.

Continue reading→

Leave a comment

Posted in Governments, Media, Medicine, Science

Tagged ,

Pfizer Steps Up Advertising for Its ‘Blockbuster’ Drug to Treat Heart Conditions, Including Those Caused by COVID Vaccines, by Michael Nevradakis, Ph.D.

Posted on March 5, 2022 | Leave a comment

It’s a nifty trick if you can manage it: get paid for a product that will fix the problems one of your other products caused. From Michael Nevradakis, Ph.D. at childrenshealthdefense.org:

Pfizer and Bristol Myers Squibb this month revived the “No Time to Wait” ad campaign urging people experiencing heart issues to visit their doctors. The two drugmakers developed and market Eliquis, the top-selling drug for the very heart conditions associated with people who received Pfizer’s COVID vaccine.

Two major pharmaceutical companies chose February, the month of love — or hearts — to launch an advertising campaign urging people experiencing heart issues for the first time to visit their doctors.

Pfizer and Bristol Myers Squibb (BMS) this month revived the “No Time to Wait” ad campaign, spending $1.28 million on TV ads alone.

The campaign warns anyone experiencing palpitations and shortness of breath that they may be at increased risk of developing atrial fibrillation (AF), deep vein thrombosis (DVT), other types of blood clots and strokes — the same types of cardiovascular ailments found among people who have received COVID-19 vaccines.

The campaign urges viewers to seek early medical attention in order to reduce the risk of these serious complications.

“Early medical attention” could include prescription drugs — including Eliquis, developed and marketed by none other than Pfizer and BMS.

According to industry publication Fierce Pharma:

“The aim is to get patients back into their doctors’ offices — and of course, if needed, be diagnosed with any relevant condition that may require them to take a blood thinner, such as Eliquis.”

Eliquis, described as a “blockbuster blood thinner and atrial fibrillation (AF) drug,” is a major revenue generator for the Pfizer-BMS alliance, delivering more than $9 billion in annual revenue — far more than competing drugs such as Xarelto (produced by Bayer in conjunction with Johnson & Johnson), and Pradaxa, produced by Boehringer Ingelheim.

Pfizer and BMS relaunched the “No Time to Wait” campaign in conjunction with several advocacy organizations and medical societies, including World Thrombosis Day, which expressed support for the Pfizer-BMS initiative as a means of “educating” the public.

Continue reading→

Leave a comment

Posted in Business, Medicine, Propaganda, Science

Tagged , ,